Fluorescence-guided sentinel node surgery for early stomach cancer
Part of Cancer, Digestive system clinical trials.
This study tests a new, less invasive surgery for early stomach cancer. A special dye is used to find the first lymph node where cancer might spread (sentinel node). If that node is cancer-free, the rest of the stomach may be saved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single, early-stage (T1N0) stomach cancer tumor, confirmed by biopsy and scans.
- Your tumor is less than 3 cm in size and at least 2 cm away from the stomach's openings (pylorus and cardia).
- You are between 20 and 80 years old.
- You are generally active (ECOG 0 or 1) and able to undergo laparoscopic or robotic stomach surgery.
- You have no history of upper abdominal surgery (except gallbladder removal), radiation to the upper abdomen, or allergic reactions to the dye used in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This trial studies whether a fluorescent dye (a “tracer”) can help surgeons find the right area during laparoscopic distal (lower-part) stomach removal for early stomach cancer. It may improve how completely the cancer is removed while keeping surgery minimally invasive.
This trial tests whether removing nearby lymph nodes is enough, or if additional stomach-sparing surgery is needed, after a previous endoscopic procedure did not completely remove early stomach cancer. The goal is to see which approach is better for preventing cancer from spreading.
This early (Phase 1) study tests a way to find the first lymph node that may be affected by stomach cancer during planned surgery. If it works safely, it could help doctors better plan treatment after surgery.
This trial tests a less invasive surgery approach for early-stage colon cancer. It uses a special dye to find and remove only the first lymph node (sentinel node) while removing just the part of the colon with the tumor, possibly avoiding a bigger surgery.
This study uses a special dye and a fluorescent camera during keyhole (laparoscopic) surgery to help doctors see and treat proximal (upper) stomach cancer. It may improve how well surgeons can find the tumor area during the operation.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.